Da. Buckley et al., THE USE OF AZATHIOPRINE IN SEVERE ADULT ATOPIC ECZEMA, JEADV. Journal of the European Academy of Dermatology and Venereology, 11(2), 1998, pp. 137-140
Aim To evaluate the use of azathioprine in the treatment of severe adu
lt atopic eczema and review the relevant literature. Background Effect
ive treatment of severe adult atopic eczema may necessitate the use of
agents such as systemic steroids, PUVA or cyclosporin, which are asso
ciated with significant morbidity. Azathioprine is an effective altern
ative which can induce disease remission and may be less toxic. Method
s Ten patients treated with azathioprine 0.7-2.5 mg/kg per day for a m
inimum period of 12 months were evaluated in a retrospective follow-up
study. Results Clearance or marked improvement was noted in eight pat
ients; three of these later became refractory to the drug. Side-effect
s were few and were well-tolerated. One patient was found to have lymp
homa 8 months after stopping treatment. Conclusion Azathioprine is an
effective and cheaper alternative to cyclosporin in the treatment of s
evere adult atopic eczema. Its long-term toxicity remains unclear. (C)
1998 Elsevier Science B.V. All rights reserved.